February 27, 2017
Allergan’s IR vice president leaves
Allergan’s Vice President of Investor Relations, Lisa DeFrancesco, has resign after being nearly 8 years of leading the Investor Relations of the company.
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
February 27, 2017
argenx and Shire extend partnership to fight rare diseases
Argenx and Shire have extended their strategic partnership from 2014 to advance the discovery and development of novel human therapeutic antibodies for diverse rare and unmet diseases for a further year until May 30, 2018.
February 27, 2017
Valeant’s Bausch + Lomb and Nicox reapply for their eye drug
Valeant Pharmaceuticals`s subsidiary, Bausch + Lomb, and Nicox have resubmitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for latanoprostene bunod ophthalmic solution, 0.024%.
February 27, 2017
Verona puts COPD candidate RPL544 in focus for 2017, NASDAQ in four months?
According to Verona Pharma’s CEO, Dr. Jan-Anders Karlsson, the highlights of 2016 were encouraging clinical data for RPL554, additional financing from “a very experienced syndicate” of investors, and further strengthening of the company’s Board and executive team.
February 27, 2017
Premaitha Health buys Taiwanese Yourgene Bioscience
Premaitha Health, an international molecular diagnostics group focused on prenatal testing, has acquired Taiwanese Yourgene Bioscience.
February 27, 2017
Midatech borrows £6 million
Midatech has borrowed £6 million from Silicn Valley Bank to add to the placing of the shares it made in October last year.
February 27, 2017
Sanofi teams up with Lonza to invest €270 million in a mammalian cell culture site in Switzerland
Sanofi and Lonza will invest €270 million (CHF 290 million) in a mammalian cell culture site for monoclonal antibody production in Swiss town of Visp, planned for opening in 2020.
February 27, 2017
CTI BioPharma appoints hematology specialist as CEO
CTI BioPharma has appointed Adam Craig, M.D., Ph.D., as President and Chief Executive Officer (CEO) and member of the Board of Directors
February 27, 2017
Global Market Insights says clinical trial management system market worth $2 billion by 2024
Growing prevalence of chronic diseases, surge in clinical trials outsourcing, rising R&D cost and favorable government initiatives will drive global clinical trial management system market size, according to a report by Global Market Insights.
February 24, 2017
Novartis makes first step in making Tafinlar + Mekinist available for certain NSCLC patients
Novartis could get first targeted treatment for patients with BRAF non-small cell lung cancer if European Medicines Agency (EMA) approves Tafinlar+Mikinist combination.